IL-20 acts as a potential target for liver diseases by combining its own receptors and signaling pathways to play a series of biofunctional regulatory roles in viral hepatitis, NAFLD, HCC and liver fibrosis. This evidence concerns the gene IL20 and hepatocellular carcinoma.